Zoom Video Communications (ZM) 10-Q 24 Aug 22 2023 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jul. 31, 2022	Aug. 12, 2022
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 31, 2022
Document Transition Report	false
Entity File Number	001-38865
Entity Registrant Name	Zoom Video Communications, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	61-1648780
Entity Address, Address Line One	55 Almaden Boulevard, 6th Floor
Entity Address, City or Town	San Jose
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95113
City Area Code	888
Local Phone Number	799-9666
Title of 12(b) Security	Class A Common Stock, $0.001 par value per share
Trading Symbol	ZM
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Entity Central Index Key	0001585521
Current Fiscal Year End Date	--01-31
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		250,975,154
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		46,669,985

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Current assets:
Cash and cash equivalents	$ 937,443	$ 1,062,820
Marketable securities	4,582,708	4,356,446
Accounts receivable, net of allowances of $32,404 and $24,696 as of July 31, 2022 and January 31, 2022, respectively	509,543	419,673
Deferred contract acquisition costs, current	225,221	199,266
Prepaid expenses and other current assets	159,486	145,602
Total current assets	6,414,401	6,183,807
Deferred contract acquisition costs, noncurrent	176,263	164,714
Property and equipment, net	239,102	222,354
Operating lease right-of-use assets	88,473	95,965
Strategic investments	358,248	367,814
Goodwill	122,556	27,607
Deferred tax assets	494,257	382,296
Other assets, noncurrent	154,298	106,761
Total assets	8,047,598	7,551,318
Current liabilities:
Accounts payable	22,994	7,841
Accrued expenses and other current liabilities	498,258	430,415
Deferred revenue, current	1,345,636	1,141,435
Total current liabilities	1,866,888	1,579,691
Deferred revenue, noncurrent	55,513	38,481
Operating lease liabilities, noncurrent	75,954	85,018
Other liabilities, noncurrent	58,846	68,110
Total liabilities	2,057,201	1,771,300
Commitments and contingencies (Note 7)
Stockholders’ equity:
Preferred stock, $0.001 par value per share, 200,000,000 shares authorized as of July 31, 2022 and January 31, 2022; zero shares issued and outstanding as of July 31, 2022 and January 31, 2022	0	0
Common stock, $0.001 par value per share, 2,000,000,000 Class A shares authorized as of July 31, 2022 and January 31, 2022; 251,411,051 and 247,044,454 shares issued and outstanding as of July 31, 2022 and January 31, 2022, respectively; 300,000,000 Class B shares authorized as of July 31, 2022 and January 31, 2022; 46,675,456 and 51,993,351 shares issued and outstanding as of July 31, 2022 and January 31, 2022, respectively	298	299
Additional paid-in capital	3,830,745	3,749,514
Accumulated other comprehensive loss	(48,161)	(17,902)
Retained earnings	2,207,515	2,048,107
Total stockholders’ equity	5,990,397	5,780,018
Total liabilities and stockholders’ equity	$ 8,047,598	$ 7,551,318

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Current assets:
Accounts receivable, allowances	$ 32,404	$ 24,696
Stockholders’ equity:
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, authorized (in shares)	200,000,000	200,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Class A Common Stock
Stockholders’ equity:
Common stock, authorized (in shares)	2,000,000,000	2,000,000,000
Common stock, issued (in shares)	251,411,051	247,044,454
Common stock, outstanding (in shares)	251,411,051	247,044,454
Class B Common Stock
Stockholders’ equity:
Common stock, authorized (in shares)	300,000,000	300,000,000
Common stock, issued (in shares)	46,675,456	51,993,351
Common stock, outstanding (in shares)	46,675,456	51,993,351

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Income Statement [Abstract]
Revenue	$ 1,099,458	$ 1,021,495	$ 2,173,258	$ 1,977,732
Cost of revenue	273,611	261,256	535,432	526,250
Gross profit	825,847	760,239	1,637,826	1,451,482
Operating expenses:
Research and development	172,564	82,311	316,855	147,486
Sales and marketing	400,474	271,179	763,257	516,846
General and administrative	131,066	112,146	248,906	266,235
Total operating expenses	704,104	465,636	1,329,018	930,567
Income from operations	121,743	294,603	308,808	520,915
(Losses) gains on strategic investments, net	(34,712)	32,076	(71,116)	32,076
Other income (expense), net	3,368	(2,795)	(3,621)	(176)
Income before provision for income taxes	90,399	323,884	234,071	552,815
Provision for income taxes	44,649	6,800	74,663	8,200
Net income	45,750	317,084	159,408	544,615
Undistributed earnings attributable to participating securities	(4)	(154)	(19)	(309)
Net income attributable to common stockholders	$ 45,746	$ 316,930	$ 159,389	$ 544,306
Net income per share attributable to common stockholders:
Basic (in dollars per share)	$ 0.15	$ 1.07	$ 0.53	$ 1.85
Diluted (in dollars per share)	$ 0.15	$ 1.04	$ 0.52	$ 1.78
Weighted-average shares used in computing net income per share attributable to common stockholders:
Basic (in shares)	298,553,379	295,712,675	298,865,676	294,769,619
Diluted (in shares)	307,160,840	305,861,051	306,902,964	305,652,628

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 45,750	$ 317,084	$ 159,408	$ 544,615
Other comprehensive loss:
Unrealized loss on available-for-sale marketable securities, net of tax	(2,924)	(53)	(30,259)	(692)
Comprehensive income	$ 42,826	$ 317,031	$ 129,149	$ 543,923

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Retained Earnings
Beginning balance (in shares) at Jan. 31, 2021		293,549,223
Beginning balance at Jan. 31, 2021	$ 3,860,767	$ 292	$ 3,187,168	$ 839	$ 672,468
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		1,593,193
Issuance of common stock upon exercise of stock options	8,237	$ 2	8,235
Issuance of common stock upon release of restricted stock units (in shares)		1,182,958
Issuance of common stock upon release of restricted stock units	1	$ 1
Issuance of common stock for employee stock purchase plan (in shares)		701,949
Issuance of common stock for employee stock purchase plan	37,846	$ 1	37,845
Stock-based compensation expense	206,974		206,974
Other comprehensive loss	(692)			(692)
Net income	544,615				544,615
Ending balance (in shares) at Jul. 31, 2021		297,027,323
Ending balance at Jul. 31, 2021	4,657,748	$ 296	3,440,222	147	1,217,083
Beginning balance (in shares) at Apr. 30, 2021		294,511,945
Beginning balance at Apr. 30, 2021	4,192,733	$ 293	3,292,241	200	899,999
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		841,507
Issuance of common stock upon exercise of stock options	4,761	$ 1	4,760
Issuance of common stock upon release of restricted stock units (in shares)		971,922
Issuance of common stock upon release of restricted stock units	1	$ 1
Issuance of common stock for employee stock purchase plan (in shares)		701,949
Issuance of common stock for employee stock purchase plan	37,846	$ 1	37,845
Stock-based compensation expense	105,376		105,376
Other comprehensive loss	(53)			(53)
Net income	317,084				317,084
Ending balance (in shares) at Jul. 31, 2021		297,027,323
Ending balance at Jul. 31, 2021	4,657,748	$ 296	3,440,222	147	1,217,083
Beginning balance (in shares) at Jan. 31, 2022		299,037,805
Beginning balance at Jan. 31, 2022	$ 5,780,018	$ 299	3,749,514	(17,902)	2,048,107
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	858,055	858,055
Issuance of common stock upon exercise of stock options	$ 5,243	$ 1	5,242
Issuance of common stock upon release of restricted stock units (in shares)		1,906,359
Issuance of common stock upon release of restricted stock units	0	$ 2	(2)
Issuance of common stock for employee stock purchase plan (in shares)		373,259
Issuance of common stock for employee stock purchase plan	34,604		34,604
Repurchase of common stock (in shares)		(4,088,971)
Repurchase of common stock	(425,946)	$ (4)	(425,942)
Stock-based compensation expense	467,329		467,329
Other comprehensive loss	(30,259)			(30,259)
Net income	159,408				159,408
Ending balance (in shares) at Jul. 31, 2022		298,086,507
Ending balance at Jul. 31, 2022	5,990,397	$ 298	3,830,745	(48,161)	2,207,515
Beginning balance (in shares) at Apr. 30, 2022		298,824,233
Beginning balance at Apr. 30, 2022	5,947,887	$ 299	3,831,060	(45,237)	2,161,765
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		314,537
Issuance of common stock upon exercise of stock options	1,899		1,899
Issuance of common stock upon release of restricted stock units (in shares)		1,439,199
Issuance of common stock upon release of restricted stock units	0	$ 2	(2)
Issuance of common stock for employee stock purchase plan (in shares)		373,259
Issuance of common stock for employee stock purchase plan	34,604		34,604
Repurchase of common stock (in shares)		(2,864,721)
Repurchase of common stock	(293,534)	$ (3)	(293,531)
Stock-based compensation expense	256,715		256,715
Other comprehensive loss	(2,924)			(2,924)
Net income	45,750				45,750
Ending balance (in shares) at Jul. 31, 2022		298,086,507
Ending balance at Jul. 31, 2022	$ 5,990,397	$ 298	$ 3,830,745	$ (48,161)	$ 2,207,515

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
Cash flows from operating activities:
Net income	$ 159,408	$ 544,615
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation expense	464,878	201,111
Amortization of deferred contract acquisition costs	119,502	79,392
Losses (gains) on strategic investments, net	71,116
(Losses) gains on strategic investments, net		(32,076)
Depreciation and amortization	36,155	22,691
Provision for accounts receivable allowances	26,727	14,592
Non-cash operating lease cost	11,067	8,633
Amortization on marketable securities	4,821	12,637
Other	19,305	264
Changes in operating assets and liabilities:
Accounts receivable	(125,898)	(117,259)
Prepaid expenses and other assets	(136,619)	(57,370)
Deferred contract acquisition costs	(157,005)	(102,597)
Accounts payable	16,441	43,960
Accrued expenses and other liabilities	64,262	93,809
Deferred revenue	220,550	296,636
Operating lease liabilities, net	(11,350)	(7,724)
Net cash provided by operating activities	783,360	1,001,314
Cash flows from investing activities:
Purchases of marketable securities	(1,576,853)	(2,094,587)
Maturities of marketable securities	1,306,676	791,906
Sales of marketable securities	0	119,569
Purchases of property and equipment	(52,870)	(92,049)
Purchases of strategic investments	(61,550)	(86,900)
Cash paid for acquisition, net of cash acquired	(120,553)	(2,121)
Purchases of intangible assets	(3,211)	0
Net cash used in investing activities	(508,361)	(1,364,182)
Cash flows from financing activities:
Cash paid for repurchases of common stock	(425,946)	0
Proceeds from issuance of common stock for employee stock purchase plan	34,605	37,846
Proceeds from employee equity transactions (remitted) to be remitted to employees and tax authorities, net	(2,545)	18,900
Proceeds from exercise of stock options	5,065	8,021
Other	0	337
Net cash (used in) provided by financing activities	(388,821)	65,104
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(16,111)	0
Net decrease in cash, cash equivalents, and restricted cash	(129,933)	(297,764)
Cash, cash equivalents, and restricted cash – beginning of period	1,073,353	2,293,116
Cash, cash equivalents, and restricted cash – end of period	943,420	1,995,352
Reconciliation of cash, cash equivalents, and restricted cash within the condensed consolidated balance sheets to the amounts shown in the condensed consolidated statements of cash flows above:
Cash and cash equivalents	937,443	1,931,370
Restricted cash, current included in prepaid expenses and other current assets	5,708	63,185
Restricted cash, noncurrent included in other assets, noncurrent	269	797
Total cash, cash equivalents, and restricted cash	$ 943,420	$ 1,995,352

Summary of Business and Signifi

Summary of Business and Significant Accounting Policies	6 Months Ended
	Jul. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Summary of Business and Significant Accounting Policies	Summary of Business and Significant Accounting Policies Description of Business Zoom Video Communications, Inc. and its subsidiaries (collectively, “Zoom,” the “Company,” “we,” “us,” or “our”) connect people through our core unified communications offering, which frictionlessly brings together video, phone, chat, webinars events, and contact center, and enables meaningful experiences across disparate devices and locations. We were incorporated in the state of Delaware in April 2011, and are headquartered in San Jose, California. Fiscal Year Our fiscal year ends on January 31. References to fiscal year 2023, for example, refer to the fiscal year ending January 31, 2023. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) and applicable regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting, and include the accounts of Zoom Video Communications, Inc., its subsidiaries, and variable interest entities for which we are the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated balance sheet as of January 31, 2022 included herein was derived from the audited financial statements as of that date, but does not include all disclosures, including certain notes required by GAAP on an annual reporting basis. The unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the balance sheets, statements of operations, statements of comprehensive income, statements of stockholders’ equity, and statements of cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year or any future period. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended January 31, 2022, filed with the SEC on March 7, 2022. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, the estimated expected benefit period for deferred contract acquisition costs, the useful lives of long-lived assets, the incremental borrowing rate for operating leases, stock-based compensation expense, sales and other tax liabilities, the fair value of marketable securities and strategic investments, acquired intangible assets and goodwill, the valuation of deferred income tax assets and uncertain tax positions, and accruals and contingencies. Actual results could materially differ from those estimates. Summary of Significant Accounting Policies Our significant accounting policies are discussed in Note 1. “Summary of Business and Significant Accounting Policies” in the notes to consolidated financial statements included in our Annual Report on Form 10-K for the year ended January 31, 2022, filed with the SEC on March 7, 2022. There have been no significant changes to these policies during the six months ended July 31, 2022. Accounting Pronouncements Not Yet Adopted In June 2022, the FASB issued ASU No. 2022-03, Fair Value Measurements (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions , which clarifies and amends the guidance of measuring the fair value of equity securities subject to contractual restrictions that prohibit the sale of the equity securities. The guidance will be effective for fiscal years beginning after December 15, 2023 and interim periods within those fiscal years. We do not expect the adoption to have a material impact on our condensed consolidated financial statements.

Revenue Recognition

Revenue Recognition	6 Months Ended
	Jul. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Disaggregation of Revenue The following table summarizes revenue by region based on the billing address of customers: Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Amount Percentage of Amount Percentage of Amount Percentage of Amount Percentage of (in thousands, except percentages) Americas $ 762,690 69 % $ 681,414 67 % $ 1,491,071 69 % $ 1,317,199 67 % Asia Pacific (“APAC”) 149,355 14 135,321 13 298,175 14 259,084 13 Europe, Middle East, and Africa (“EMEA”) 187,413 17 204,760 20 384,012 17 401,449 20 Total $ 1,099,458 100 % $ 1,021,495 100 % $ 2,173,258 100 % $ 1,977,732 100 % Contract Balances We receive payments from customers based on a billing schedule as established in our customer contracts. Accounts receivable are recorded when we contractually have the right to consideration. In some arrangements, a right to consideration for our performance under the customer contract may occur before invoicing to the customer, resulting in an unbilled accounts receivable. The amount of unbilled accounts receivable included within accounts receivable, net of allowances on the condensed consolidated balance sheets was $70.6 million and $59.7 million as of July 31, 2022 and January 31, 2022, respectively. Contract liabilities consist of deferred revenue. Revenue is deferred when we have the right to invoice in advance of performance under a customer contract. The current portion of deferred revenue balances is recognized over the next 12 months. The amount of revenue recognized during the three months ended July 31, 2022 and 2021 that was included in deferred revenue at the beginning of each period was $572.7 million and $480.5 million, respectively, and $867.6 million and $660.1 million during the six months ended July 31, 2022 and 2021, respectively. Remaining Performance Obligations The terms of our subscription agreements are monthly, annual, and multiyear, and we may bill for the full term in advance or on an annual, quarterly, or monthly basis, depending on the billing terms with customers. As of July 31, 2022, the aggregate amount of the transaction price allocated to our remaining performance obligations was $3,213.0 million, which consists of both billed consideration in the amount of $1,401.1 million and unbilled consideration in the amount of $1,811.9 million that we expect to recognize as revenue. We expect to recognize 61% of our remaining performance obligations as revenue over the next 12 months and the remainder thereafter.

Investments

Investments	6 Months Ended
	Jul. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Investments	Investments Marketable Securities As of July 31, 2022 and January 31, 2022, our marketable securities consisted of the following: As of July 31, 2022 Amortized Gross Gross Estimated (in thousands) Commercial paper $ 64,596 $ — $ — $ 64,596 Agency bonds 654,632 165 (10,965) 643,832 Corporate and other debt securities 411,999 81 (3,615) 408,465 U.S. government agency securities 3,433,437 344 (49,538) 3,384,243 Treasury bills 81,819 — (247) 81,572 Marketable securities $ 4,646,483 $ 590 $ (64,365) $ 4,582,708 As of January 31, 2022 Amortized Gross Gross Estimated (in thousands) Commercial paper $ 28,723 $ — $ — $ 28,723 Agency bonds 632,935 2 (3,328) 629,609 Corporate and other debt securities 282,124 5 (1,202) 280,927 U.S. government agency securities 3,046,742 28 (19,261) 3,027,509 Treasury bills 389,826 — (148) 389,678 Marketable securities $ 4,380,350 $ 35 $ (23,939) $ 4,356,446 Unrealized losses for securities that have been in an unrealized loss position for less than 12 months were $56.4 million as of July 31, 2022 and $23.3 million as of January 31, 2022. Unrealized losses for securities that have been in an unrealized loss position for 12 months or longer were $8.0 million as of July 31, 2022 and were immaterial as of January 31, 2022. We review the individual securities that have unrealized losses on a regular basis to evaluate whether or not any security has experienced, or is expected to experience, credit losses resulting in the decline in fair value. We evaluate, among other factors, whether we have the intention to sell any of these marketable securities and whether it is more likely than not that we will be required to sell any of them before recovery of the amortized cost basis. We have not recorded an allowance for credit losses, as we believe any such losses would be immaterial based on the high-grade credit rating for each of our marketable securities as of the end of each period. There were no material realized gains or losses from available-for-sale securities that were reclassified out of accumulated other comprehensive loss for the three and six months ended July 31, 2022 and 2021. The following table presents the contractual maturities of our marketable securities as of July 31, 2022 and January 31, 2022: As of July 31, 2022 January 31, 2022 (in thousands) Less than one year $ 2,827,538 $ 2,387,139 Due in one to five years 1,755,170 1,969,307 Total $ 4,582,708 $ 4,356,446 Strategic Investments Strategic investments by form and measurement category as of July 31, 2022 were as follows: Measurement Category Fair Value Measurement Alternative Equity Method Total (in thousands) Equity securities $ 139,908 $ 112,064 $ 92,603 $ 344,575 Debt securities 13,673 — — 13,673 Strategic investments $ 153,581 $ 112,064 $ 92,603 $ 358,248 Strategic investments by form and measurement category as of January 31, 2022 were as follows: Measurement Category Fair Value Measurement Alternative Equity Method Total (in thousands) Equity securities $ 168,784 $ 91,399 $ 93,400 $ 353,583 Debt securities 14,231 — — 14,231 Strategic investments $ 183,015 $ 91,399 $ 93,400 $ 367,814 In the second quarter of fiscal year 2023, we made a strategic investment of $40.0 million for common shares in a company in the B2B software and services travel space's private placement. We recorded a loss of $12.2 million related to this investment for the three months ended July 31, 2022. As of July 31, 2022, the fair value of the investment was $27.8 million and our ownership interest represents less than 1% percent of the economic interest of the investee's outstanding capital stock.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jul. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The following tables present information about our financial instruments that are measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation inputs utilized to determine such fair value: As of July 31, 2022 Fair Value Level 1 Level 2 Level 3 (in thousands) Financial Assets: Money market funds $ 521,527 $ 521,527 $ — $ — Treasury bills 50 — 50 — Commercial paper 670 — 670 — U.S. government agency securities 49,197 — 49,197 — Agency bonds 15,949 — 15,949 — Cash equivalents 587,393 521,527 65,866 — Commercial paper 64,596 — 64,596 — Agency bonds 643,832 — 643,832 — Corporate and other debt securities 408,465 — 408,465 — U.S. government agency securities 3,384,243 — 3,384,243 — Treasury bills 81,572 — 81,572 — Marketable securities 4,582,708 — 4,582,708 — Publicly held equity securities included in strategic investments 139,908 139,908 — — Privately held debt securities included in strategic investments 13,673 — — 13,673 Certificates of deposit included in other assets, noncurrent 269 — 269 — Total financial assets $ 5,323,951 $ 661,435 $ 4,648,843 $ 13,673 As of January 31, 2022 Fair Value Level 1 Level 2 Level 3 (in thousands) Financial Assets: Money market funds $ 688,722 $ 688,722 $ — $ — Treasury bills 107,496 — 107,496 — Corporate debt securities 749 — 749 — Cash equivalents 796,967 688,722 108,245 — Commercial paper 28,723 — 28,723 — Agency bonds 629,609 — 629,609 — Corporate and other debt securities 280,927 — 280,927 — U.S. government agency securities 3,027,509 — 3,027,509 — Treasury bills 389,678 — 389,678 — Marketable securities 4,356,446 — 4,356,446 — Certificates of deposit included in other assets, noncurrent 297 — 297 — Publicly held equity securities included in strategic investments 168,784 168,784 — — Privately held debt securities included in strategic investments 14,231 — — 14,231 Total financial assets $ 5,336,725 $ 857,506 $ 4,464,988 $ 14,231 We classify our highly liquid money market funds and publicly held equity securities within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. We classify our commercial paper, agency bonds, corporate and other debt securities, U.S. government agency securities, treasury bills, and certificates of deposit within Level 2 because they are valued using inputs other than quoted prices that are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security, which may not be actively traded. We classify our privately held debt securities as Level 3 due to the lack of relevant observable market data over fair value inputs, such as the probability weighting of the various scenarios that can impact settlement of the arrangement.

Business Combinations

Business Combinations	6 Months Ended
	Jul. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Business Combinations	Business Combinations On May 19, 2022, we acquired 100% of the issued and outstanding share capital of Solvvy, Inc., a private technology company specializing in customer support automation, for an all-cash purchase consideration of $121.2 million. The acquisition adds to our customer service capabilities and enhances our integrated platform by providing conversational AI capabilities. The acquisition has been accounted for as a business combination. In allocating the purchase consideration, $94.9 million was attributed to goodwill, $26.7 million to intangible assets (consisted of $12.0 million to developed technology and $14.7 million to customer relationships), and $0.4 million to other net liabilities acquired. The goodwill amount represents synergies related to our existing products expected to be realized from the acquisition and assembled workforce. The associated goodwill is not deductible for tax purposes. At the date of the acquisition, the developed technology and customer relationships both had an estimated useful life of 5.0 years, and both are amortized using the straight-line method over their respective estimated useful lives. As of July 31, 2022, the developed technology and customer relationships both had a remaining useful life of 4.8 years. Transaction costs incurred in connection with the acquisition were immaterial. The results of operations of Solvvy, Inc., which are not material, have been included in our condensed consolidated financial statements from the date of the acquisition. Pro forma and historical results of operations of the company have not been presented, as the results do not have a material effect on any of the periods presented in our condensed consolidated statements of operations. Uncertain tax positions are initially established in connection with the acquisition as of the acquisition date. We continue to collect information and reevaluate these estimates and assumptions quarterly. We will record any adjustments to our preliminary estimates to goodwill, provided that it is within the one-year measurement period.

Balance Sheet Components

Balance Sheet Components	6 Months Ended
	Jul. 31, 2022
Balance Sheet Components [Abstract]
Balance Sheet Components	Balance Sheet Components Accounts Receivable, Net Accounts receivable are recorded for invoiced amounts and amounts for which revenue has been recognized, but not invoiced, net of allowances. Our short-term accounts receivable consist of the following: As of July 31, 2022 January 31, 2022 (in thousands) Accounts receivable, gross $ 541,947 $ 444,369 Less: allowance for credit losses (23,200) (17,000) Less: allowance for returns (9,204) (7,696) Accounts receivable, net $ 509,543 $ 419,673 Below is a rollforward of our allowance for credit losses for the six months ended July 31, 2022 and 2021: 2022 2021 (in thousands) Balance as of January 31 $ 17,000 $ 20,500 Provision for credit losses 25,606 8,029 Write-offs (19,406) (11,029) Balance as of July 31 $ 23,200 $ 17,500 Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following: As of July 31, 2022 January 31, 2022 (in thousands) Prepaid expenses $ 126,857 $ 112,666 Other receivables 17,211 20,423 Restricted cash from international employee stock sales 5,708 10,236 Other 9,710 2,277 Prepaid expenses and other current assets $ 159,486 $ 145,602 Property and Equipment, Net Property and equipment consisted of the following: As of July 31, 2022 January 31, 2022 (in thousands) Servers $ 213,578 $ 185,491 Software 69,692 59,153 Computer and office equipment 45,241 39,410 Leasehold improvements 25,313 25,340 Furniture and fixtures 4,568 4,565 Property and equipment, gross 358,392 313,959 Less: accumulated depreciation and amortization (119,290) (91,605) Property and equipment, net $ 239,102 $ 222,354 Depreciation and amortization expense was $19.6 million and $11.8 million for the three months ended July 31, 2022 and 2021, respectively, and $34.7 million and $22.3 million for the six months ended July 31, 2022 and 2021, respectively. Other Assets, Noncurrent Other assets, noncurrent consisted of the following: As of July 31, 2022 January 31, 2022 (in thousands) Accounts receivable, noncurrent $ 82,175 $ 55,643 Intangible assets subject to amortization, net 28,174 2,972 Indefinite-lived intangible assets 24,232 21,020 Prepaid expenses, noncurrent 9,746 16,120 Other 9,971 11,006 Other assets, noncurrent $ 154,298 $ 106,761 Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following: As of July 31, 2022 January 31, 2022 (in thousands) Accrued expenses $ 168,860 $ 149,658 Accrued compensation and benefits 127,236 126,322 Income tax liabilities 106,313 56,968 Sales and other non-income tax liabilities 34,103 33,305 Customer deposit liabilities 23,703 20,884 Operating lease liabilities, current 21,986 20,697 Other 16,057 22,581 Accrued expenses and other current liabilities $ 498,258 $ 430,415 Other Liabilities, Noncurrent Other liabilities, noncurrent consisted of the following: As of July 31, 2022 January 31, 2022 (in thousands) Sales and other non-income tax liabilities $ 41,747 $ 53,916 Other 17,099 14,194 Other liabilities, noncurrent $ 58,846 $ 68,110

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jul. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Non-cancelable Purchase Obligations During the six months ended July 31, 2022, there have been no material changes to our non-cancelable purchase obligations from those disclosed in Note 8. “Commitments and Contingencies” in the notes to consolidated financial statements included in our Annual Report on Form 10-K for the year ended January 31, 2022, filed with the SEC on March 7, 2022. Other Contingencies In June 2020, we received a grand jury subpoena from the Department of Justice’s U.S. Attorney’s Office for Eastern District of New York (“EDNY”), which requested information regarding our interactions with foreign governments and foreign political parties, including the Chinese government, as well as information regarding storage of and access to user data, the development and implementation of Zoom’s privacy policies, and the actions we took relating to the Tiananmen commemorations on Zoom. In July 2020, we received subpoenas from the Department of Justice’s U.S. Attorney’s Office for the Northern District of California (“NDCA”) and the SEC. Both subpoenas seek documents and information relating to various security, data protection and privacy matters, including our encryption, and our statements relating thereto, as well as calculation of usage metrics and related public statements. In addition, the NDCA subpoena seeks information relating to any contacts between our employees and representatives of the Chinese government, and any attempted or successful influence by any foreign government in our policies, procedures, practices, and actions as they relate to users in the United States. We have since received additional subpoenas from EDNY and NDCA seeking related information. We are fully cooperating with all of these investigations and have been conducting our own thorough internal investigation. These investigations are ongoing, and we do not know when they will be completed, which facts we will ultimately discover as a result of the investigations, or what actions the government may or may not take. We cannot predict the outcome of these investigations, and a negative outcome in any or all of these matters could cause us to incur substantial fines, penalties, or other financial exposure, as well as reputational harm. Legal Proceedings On April 7, 2020 and April 8, 2020, securities class action complaints were filed against us and two of our officers in the United States District Court for the NDCA. The plaintiffs are purported stockholders of the Company. The complaints allege, among other things, that we violated Sections 10(b) and 20(a) of the Exchange Act, and Rule 10b-5 by making false and misleading statements and omissions of material fact about our data privacy and security measures. The complaints seek unspecified damages, interest, fees, and costs. On May 18, 2020, the actions were consolidated. On November 4, 2020, the court appointed a lead plaintiff. On December 23, 2020, the lead plaintiff filed a consolidated complaint. We filed a motion to dismiss the consolidated complaint on May 20, 2021. Plaintiff filed an opposition to our motion to dismiss on July 9, 2021. Our reply in support of the motion to dismiss was filed on August 9, 2021. On February 16, 2022, the court granted in part, and denied in part, our motion to dismiss. On March 14, 2022, we moved for reconsideration of the court’s ruling on the motion to dismiss. On March 22, 2022, the court ordered plaintiff to respond to our motion, which plaintiff did on March 29, 2022. On April 22, 2022, we answered the complaint. On June 11, 2020 and July 30, 2020, purported shareholder derivative complaints were filed in the United States District Court for the District of Delaware. The first complaint names as defendants nine of our officers and directors, and the second complaint names eight of our officers and directors. The lawsuits assert state and federal claims and are based on the same alleged misstatements as the shareholder class action complaint. The lawsuits accuse our board of directors of failing to exercise reasonable and prudent supervision over our management, policies, practices, and internal controls. The plaintiffs seek unspecified monetary damages on behalf of us as well as governance reforms. On September 25, 2020, the derivative cases were consolidated. The consolidated case is stayed pending resolution of the motion to dismiss the securities class action. On October 27, 2021, a third substantially identical lawsuit was filed in the same court against the same defendants, seeking unspecified monetary damages and governance reforms. On November 17, 2021, all three derivative lawsuits were consolidated and remain stayed pending resolution of the motion to dismiss the securities class action. We believe these lawsuits are without merit, and we are vigorously defending ourselves against them. Given the uncertainty of litigation, the preliminary stage of the cases, and the legal standards that must be met for, among other things, class certification and success on the merits, we cannot estimate the reasonably possible loss or range of loss that may result from these actions. Beginning on March 30, 2020, multiple putative class actions were filed against us in various U.S. federal district courts and state courts relating to our alleged privacy and security practices, including alleged data sharing with third parties (the “U.S. Privacy Class Actions”). The plaintiffs claim violations of a variety of state consumer protection and privacy laws, and also assert state constitutional and common law claims, such as negligence and unjust enrichment. The U.S. Privacy Class Actions seek to certify both nationwide and state-specific classes of individuals using our services in certain time periods. The plaintiffs seek various forms of injunctive and monetary relief, including restitution, statutory and actual damages, punitive damages, and attorneys’ fees. The federal cases have been transferred to and consolidated in the NDCA with our consent; lead plaintiffs’ counsel have been appointed; and plaintiffs filed their first amended consolidated class action complaint on October 28, 2020. On March 11, 2021, the court granted in part, and denied in part, our motion to dismiss, and gave plaintiffs leave to amend. On July 30, 2021, we entered into a settlement agreement with plaintiffs to settle the action on a classwide basis, and plaintiffs filed a motion for preliminary approval of the settlement with the court on July 31, 2021. On October 21, 2021, the Court preliminarily approved the settlement. Under the terms of the settlement, we have paid $85.0 million into an escrow account

Stockholders_ Equity and Equity

Stockholders’ Equity and Equity Incentive Plans	6 Months Ended
	Jul. 31, 2022
Stockholders' Equity Note [Abstract]
Stockholders’ Equity and Equity Incentive Plans	Stockholders’ Equity and Equity Incentive Plans Common Stock Our amended and restated certificate of incorporation authorizes the issuance of 2,000,000,000 shares of Class A common stock, $0.001 par value per share, and 300,000,000 shares of Class B common stock, $0.001 par value per share. Class A and Class B common stock are referred to as common stock throughout the notes to the condensed consolidated financial statements, unless otherwise noted. Stock Repurchase Plan In February 2022, our Board of Directors authorized a stock repurchase program of up to $1.0 billion of our Class A common stock, which expires in February 2024. Repurchases of our Class A common stock may be effected from time to time, either on the open market (including preset trading plans), in privately negotiated transactions, and other transactions in accordance with applicable securities laws. The program does not obligate us to repurchase any specific number of shares and may be discontinued at any time. During the three and six months ended July 31, 2022 , we repurchased and subsequently retired 2,864,721 and 4,088,971 shares of our Class A common stock, respectively, for an aggregate amount of $293.5 million and $425.9 million , respectively. As of July 31, 2022 , $574.1 million of the repurchase authorization remained available. Equity Incentive Plans We have two equity incentive plans: the 2011 Global Share Plan (“2011 Plan”) and the 2019 Equity Incentive Plan (“2019 Plan”). All shares that remain available for future grants are under the 2019 Plan. Stock Options A summary of stock option activity under our equity incentive plan and related information is as follows: Stock Options Outstanding Weighted- Weighted- Aggregate (in thousands, except share, life, and per share data) Balance as of January 31, 2022 6,195,205 $ 8.08 6.0 $ 905,744 Exercised (858,055) $ 5.90 $ 91,811 Canceled/forfeited/expired (83,072) $ 21.48 Outstanding as of July 31, 2022 5,254,078 $ 8.22 5.5 $ 502,488 Vested and expected to vest as of July 31, 2022 5,254,078 $ 8.22 5.5 $ 502,488 Exercisable as of July 31, 2022 4,869,691 $ 6.81 5.4 $ 472,618 As of July 31, 2022, unrecognized stock-based compensation expense related to outstanding unvested stock options was $7.3 million, which is expected to be recognized over a weighted-average period of 0.5 years. Restricted Stock Units A summary of restricted stock unit (“RSU”) activity under our equity incentive plan and related information is as follows: RSUs Unvested Weighted- Unvested as of January 31, 2022 5,546,366 $ 232.58 Granted 10,737,425 $ 110.99 Vested (1,906,359) $ 189.17 Canceled/forfeited (826,734) $ 173.54 Unvested as of July 31, 2022 13,550,698 $ 145.93 In March 2022, a change made to our equity compensation program resulted in the modification of the value of RSUs offered to our employees. This activity has been included in our total Stock-Based Compensation disclosures below. As of July 31, 2022, unrecognized stock-based compensation expense related to RSUs was $2,481.1 million, including the impact of the modification, which is expected to be recognized over a weighted-average period of 3.0 years. 2019 Employee Stock Purchase Plan In April 2019, we adopted the 2019 Employee Stock Purchase Plan (“ESPP”). As of July 31, 2022, unrecognized stock-based compensation expense related to the ESPP was $85.5 million, which is expected to be recognized over a weighted-average period of 1.5 years. Stock-Based Compensation The stock-based compensation expense by line item in the accompanying condensed consolidated statements of operations is summarized as follows: Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 (in thousands) Cost of revenue $ 37,177 $ 14,778 $ 68,327 $ 28,844 Research and development 69,701 22,917 125,452 43,736 Sales and marketing 110,161 50,856 203,956 102,668 General and administrative 38,476 13,591 67,143 25,863 Total stock-based compensation expense $ 255,515 $ 102,142 464,878 201,111 Benefit from income taxes (54,117) — (97,032) — Total stock-based compensation expense recorded to net income $ 201,398 $ 102,142 $ 367,846 $ 201,111

Income Taxes

Income Taxes	6 Months Ended
	Jul. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes We compute our provision for income taxes by applying the estimated annual effective tax rate to year-to-date ordinary income and adjust the provision for discrete tax items recorded in the period. In each quarter, we update the estimated annual effective tax rate and make a year-to-date adjustment to the provision. The estimated annual effective tax rate is subject to significant volatility due to several factors, including our ability to accurately predict the proportion of our pretax income in multiple jurisdictions and certain book-tax differences. The following table provides details of the provision for income taxes: Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 (in thousands, except percentages) Income before provision for income taxes $ 90,399 $ 323,884 $ 234,071 $ 552,815 Provision for income taxes 44,649 6,800 74,663 8,200 Effective tax rate 49.4 % 2.1 % 31.9 % 1.5 % We had a provision for income taxes of $44.6 million and $6.8 million for the three months ended July 31, 2022 and 2021, respectively. The provision for income taxes was $74.7 million and $8.2 million for the six months ended July 31, 2022 and 2021, respectively. The year-over-year increase in effective tax rate for the three and six month periods ended July 31, 2022 was due primarily to tax shortfalls on share based compensation and the valuation allowance recorded on the deferred tax asset related to losses that are capital in nature as of July 31, 2022 compared to the full valuation allowance on the U.S. deferred tax assets as of July 31, 2021, which was released in the fourth quarter of fiscal year 2022. For the three and six months ended July 31, 2022, the effective tax rate differed from the U.S. federal statutory rate due primarily to tax shortfalls on share based compensation, and the valuation allowance recorded on the deferred tax asset related to losses that are capital in nature, partially offset by research credits and the foreign-derived intangible income deduction. For the three and six months ended July 31, 2021, the effective tax rate differed from the U.S. federal statutory rate due primarily to the full valuation allowance on the U.S. deferred tax assets. The realization of tax benefits of net deferred tax assets is dependent upon future levels of taxable income, of an appropriate character, in the periods the items are expected to be deductible or taxable. Based on the available objective evidence during the three and six months ended July 31, 2022, we continue to believe that it is more likely than not that the tax benefits of the U.K. net deferred tax assets may not be realized. Accordingly, we maintained a full valuation allowance against the tax benefits of these net deferred tax assets. Based on the available objective evidence during the three and six months ended July 31, 2022, we believe that it is more likely than not that the tax benefits relating to U.S. losses that are capital in nature may not be realized prior to expiration. Accordingly, we have recorded a valuation allowance during the quarter against these deferred tax assets. We intend to maintain the applicable valuation allowance until sufficient positive evidence exists to support a reversal of, or decrease in, the valuation allowance. During the three and six months ended July 31, 2022, there were no material changes to the total amount of unrecognized tax benefits and we do not expect any significant changes in the next 12 months.

Net Income Per Share Attributab

Net Income Per Share Attributable to Common Stockholders	6 Months Ended
	Jul. 31, 2022
Earnings Per Share [Abstract]
Net Income Per Share Attributable to Common Stockholders	Net Income Per Share Attributable to Common Stockholders The following table sets forth the computation of basic and diluted net income per share attributable to common stockholders for the periods presented: Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Class A Class B Class A Class B Class A Class B Class A Class B (in thousands, except share and per share data) Numerator: Net income $ 38,594 $ 7,156 $ 255,513 $ 61,571 $ 134,075 $ 25,333 $ 431,889 $ 112,726 Less: undistributed earnings attributable to participating securities — (4) — (154) — (19) — (309) Net income attributable to common stockholders, basic $ 38,594 $ 7,152 $ 255,513 $ 61,417 $ 134,075 $ 25,314 $ 431,889 $ 112,417 Reallocation of net income attributable to common stockholders (518) 518 (5,738) 5,738 (1,959) 1,959 (10,105) 10,105 Net income attributable to common stockholders, diluted $ 38,076 $ 7,670 $ 249,775 $ 67,155 $ 132,116 $ 27,273 $ 421,784 $ 122,522 Denominator: Weighted-average shares used in computing net income per share attributable to common stockholders, basic 251,878,556 46,674,823 238,407,148 57,305,527 251,400,283 47,465,393 233,889,833 60,879,786 Weighted-average shares used in computing net income per share attributable to common stockholders, diluted 255,661,184 51,499,656 241,051,560 64,809,491 254,389,537 52,513,427 236,850,849 68,801,779 Net income per share attributable to common stockholders, basic $ 0.15 $ 0.15 $ 1.07 $ 1.07 $ 0.53 $ 0.53 $ 1.85 $ 1.85 Net income per share attributable to common stockholders, diluted $ 0.15 $ 0.15 $ 1.04 $ 1.04 $ 0.52 $ 0.52 $ 1.78 $ 1.78 The potential shares of common stock that were excluded from the computation of diluted net income per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive, are as follows: Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Class A Class B Class A Class B Class A Class B Class A Class B Unvested RSUs 6,451,823 — 323,313 — 5,113,608 — 301,179 — Purchase rights committed under the ESPP 1,757,812 — 247,321 — 995,341 — 134,576 — Outstanding stock options 103,406 — — — 51,703 — — — Total 8,313,041 — 570,634 — 6,160,652 — 435,755 — The table above does not include 405,156 shares of issued Class A common stock held by us as of July 31, 2022 and 2021 that are reserved for the sole purpose of being transferred to nonprofit organizations.

Summary of Business and Signi_2

Summary of Business and Significant Accounting Policies (Policies)	6 Months Ended
	Jul. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) and applicable regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting, and include the accounts of Zoom Video Communications, Inc., its subsidiaries, and variable interest entities for which we are the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, the estimated expected benefit period for deferred contract acquisition costs, the useful lives of long-lived assets, the incremental borrowing rate for operating leases, stock-based compensation expense, sales and other tax liabilities, the fair value of marketable securities and strategic investments, acquired intangible assets and goodwill, the valuation of deferred income tax assets and uncertain tax positions, and accruals and contingencies. Actual results could materially differ from those estimates.
Accounting Pronouncements Not Yet Adopted	Accounting Pronouncements Not Yet Adopted In June 2022, the FASB issued ASU No. 2022-03, Fair Value Measurements (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions , which clarifies and amends the guidance of measuring the fair value of equity securities subject to contractual restrictions that prohibit the sale of the equity securities. The guidance will be effective for fiscal years beginning after December 15, 2023 and interim periods within those fiscal years. We do not expect the adoption to have a material impact on our condensed consolidated financial statements.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	6 Months Ended
	Jul. 31, 2022
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue by Region	The following table summarizes revenue by region based on the billing address of customers: Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Amount Percentage of Amount Percentage of Amount Percentage of Amount Percentage of (in thousands, except percentages) Americas $ 762,690 69 % $ 681,414 67 % $ 1,491,071 69 % $ 1,317,199 67 % Asia Pacific (“APAC”) 149,355 14 135,321 13 298,175 14 259,084 13 Europe, Middle East, and Africa (“EMEA”) 187,413 17 204,760 20 384,012 17 401,449 20 Total $ 1,099,458 100 % $ 1,021,495 100 % $ 2,173,258 100 % $ 1,977,732 100 %

Investments (Tables)

Investments (Tables)	6 Months Ended
	Jul. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Schedule of Marketable Securities	As of July 31, 2022 and January 31, 2022, our marketable securities consisted of the following: As of July 31, 2022 Amortized Gross Gross Estimated (in thousands) Commercial paper $ 64,596 $ — $ — $ 64,596 Agency bonds 654,632 165 (10,965) 643,832 Corporate and other debt securities 411,999 81 (3,615) 408,465 U.S. government agency securities 3,433,437 344 (49,538) 3,384,243 Treasury bills 81,819 — (247) 81,572 Marketable securities $ 4,646,483 $ 590 $ (64,365) $ 4,582,708 As of January 31, 2022 Amortized Gross Gross Estimated (in thousands) Commercial paper $ 28,723 $ — $ — $ 28,723 Agency bonds 632,935 2 (3,328) 629,609 Corporate and other debt securities 282,124 5 (1,202) 280,927 U.S. government agency securities 3,046,742 28 (19,261) 3,027,509 Treasury bills 389,826 — (148) 389,678 Marketable securities $ 4,380,350 $ 35 $ (23,939) $ 4,356,446
Schedule of Contractual Maturities of Marketable Securities	The following table presents the contractual maturities of our marketable securities as of July 31, 2022 and January 31, 2022: As of July 31, 2022 January 31, 2022 (in thousands) Less than one year $ 2,827,538 $ 2,387,139 Due in one to five years 1,755,170 1,969,307 Total $ 4,582,708 $ 4,356,446
Schedule of Strategic Investments	Strategic investments by form and measurement category as of July 31, 2022 were as follows: Measurement Category Fair Value Measurement Alternative Equity Method Total (in thousands) Equity securities $ 139,908 $ 112,064 $ 92,603 $ 344,575 Debt securities 13,673 — — 13,673 Strategic investments $ 153,581 $ 112,064 $ 92,603 $ 358,248 Strategic investments by form and measurement category as of January 31, 2022 were as follows: Measurement Category Fair Value Measurement Alternative Equity Method Total (in thousands) Equity securities $ 168,784 $ 91,399 $ 93,400 $ 353,583 Debt securities 14,231 — — 14,231 Strategic investments $ 183,015 $ 91,399 $ 93,400 $ 367,814

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jul. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Financial Instruments Measured at Fair Value on Recurring Basis	The following tables present information about our financial instruments that are measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation inputs utilized to determine such fair value: As of July 31, 2022 Fair Value Level 1 Level 2 Level 3 (in thousands) Financial Assets: Money market funds $ 521,527 $ 521,527 $ — $ — Treasury bills 50 — 50 — Commercial paper 670 — 670 — U.S. government agency securities 49,197 — 49,197 — Agency bonds 15,949 — 15,949 — Cash equivalents 587,393 521,527 65,866 — Commercial paper 64,596 — 64,596 — Agency bonds 643,832 — 643,832 — Corporate and other debt securities 408,465 — 408,465 — U.S. government agency securities 3,384,243 — 3,384,243 — Treasury bills 81,572 — 81,572 — Marketable securities 4,582,708 — 4,582,708 — Publicly held equity securities included in strategic investments 139,908 139,908 — — Privately held debt securities included in strategic investments 13,673 — — 13,673 Certificates of deposit included in other assets, noncurrent 269 — 269 — Total financial assets $ 5,323,951 $ 661,435 $ 4,648,843 $ 13,673 As of January 31, 2022 Fair Value Level 1 Level 2 Level 3 (in thousands) Financial Assets: Money market funds $ 688,722 $ 688,722 $ — $ — Treasury bills 107,496 — 107,496 — Corporate debt securities 749 — 749 — Cash equivalents 796,967 688,722 108,245 — Commercial paper 28,723 — 28,723 — Agency bonds 629,609 — 629,609 — Corporate and other debt securities 280,927 — 280,927 — U.S. government agency securities 3,027,509 — 3,027,509 — Treasury bills 389,678 — 389,678 — Marketable securities 4,356,446 — 4,356,446 — Certificates of deposit included in other assets, noncurrent 297 — 297 — Publicly held equity securities included in strategic investments 168,784 168,784 — — Privately held debt securities included in strategic investments 14,231 — — 14,231 Total financial assets $ 5,336,725 $ 857,506 $ 4,464,988 $ 14,231

Balance Sheet Components (Table

Balance Sheet Components (Tables)	6 Months Ended
	Jul. 31, 2022
Balance Sheet Components [Abstract]
Schedule of Accounts Receivable	Our short-term accounts receivable consist of the following: As of July 31, 2022 January 31, 2022 (in thousands) Accounts receivable, gross $ 541,947 $ 444,369 Less: allowance for credit losses (23,200) (17,000) Less: allowance for returns (9,204) (7,696) Accounts receivable, net $ 509,543 $ 419,673
Schedule of Accounts Receivable, Allowance for Credit Loss	Below is a rollforward of our allowance for credit losses for the six months ended July 31, 2022 and 2021: 2022 2021 (in thousands) Balance as of January 31 $ 17,000 $ 20,500 Provision for credit losses 25,606 8,029 Write-offs (19,406) (11,029) Balance as of July 31 $ 23,200 $ 17,500
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consisted of the following: As of July 31, 2022 January 31, 2022 (in thousands) Prepaid expenses $ 126,857 $ 112,666 Other receivables 17,211 20,423 Restricted cash from international employee stock sales 5,708 10,236 Other 9,710 2,277 Prepaid expenses and other current assets $ 159,486 $ 145,602
Schedule of Property and Equipment	Property and equipment consisted of the following: As of July 31, 2022 January 31, 2022 (in thousands) Servers $ 213,578 $ 185,491 Software 69,692 59,153 Computer and office equipment 45,241 39,410 Leasehold improvements 25,313 25,340 Furniture and fixtures 4,568 4,565 Property and equipment, gross 358,392 313,959 Less: accumulated depreciation and amortization (119,290) (91,605) Property and equipment, net $ 239,102 $ 222,354
Schedule of Other Noncurrent Assets	Other assets, noncurrent consisted of the following: As of July 31, 2022 January 31, 2022 (in thousands) Accounts receivable, noncurrent $ 82,175 $ 55,643 Intangible assets subject to amortization, net 28,174 2,972 Indefinite-lived intangible assets 24,232 21,020 Prepaid expenses, noncurrent 9,746 16,120 Other 9,971 11,006 Other assets, noncurrent $ 154,298 $ 106,761
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consisted of the following: As of July 31, 2022 January 31, 2022 (in thousands) Accrued expenses $ 168,860 $ 149,658 Accrued compensation and benefits 127,236 126,322 Income tax liabilities 106,313 56,968 Sales and other non-income tax liabilities 34,103 33,305 Customer deposit liabilities 23,703 20,884 Operating lease liabilities, current 21,986 20,697 Other 16,057 22,581 Accrued expenses and other current liabilities $ 498,258 $ 430,415
Schedule of Other Liabilities Non Current	Other liabilities, noncurrent consisted of the following: As of July 31, 2022 January 31, 2022 (in thousands) Sales and other non-income tax liabilities $ 41,747 $ 53,916 Other 17,099 14,194 Other liabilities, noncurrent $ 58,846 $ 68,110

Stockholders_ Equity and Equi_2

Stockholders’ Equity and Equity Incentive Plans (Tables)	6 Months Ended
	Jul. 31, 2022
Stockholders' Equity Note [Abstract]
Schedule of Stock Option Activity Under Equity Incentive Plan	A summary of stock option activity under our equity incentive plan and related information is as follows: Stock Options Outstanding Weighted- Weighted- Aggregate (in thousands, except share, life, and per share data) Balance as of January 31, 2022 6,195,205 $ 8.08 6.0 $ 905,744 Exercised (858,055) $ 5.90 $ 91,811 Canceled/forfeited/expired (83,072) $ 21.48 Outstanding as of July 31, 2022 5,254,078 $ 8.22 5.5 $ 502,488 Vested and expected to vest as of July 31, 2022 5,254,078 $ 8.22 5.5 $ 502,488 Exercisable as of July 31, 2022 4,869,691 $ 6.81 5.4 $ 472,618
Schedule of Restricted Stock Units (RSUs) Activity Under Equity Incentive Plan	A summary of restricted stock unit (“RSU”) activity under our equity incentive plan and related information is as follows: RSUs Unvested Weighted- Unvested as of January 31, 2022 5,546,366 $ 232.58 Granted 10,737,425 $ 110.99 Vested (1,906,359) $ 189.17 Canceled/forfeited (826,734) $ 173.54 Unvested as of July 31, 2022 13,550,698 $ 145.93
Schedule of Stock-based Compensation Expense by Line Item	The stock-based compensation expense by line item in the accompanying condensed consolidated statements of operations is summarized as follows: Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 (in thousands) Cost of revenue $ 37,177 $ 14,778 $ 68,327 $ 28,844 Research and development 69,701 22,917 125,452 43,736 Sales and marketing 110,161 50,856 203,956 102,668 General and administrative 38,476 13,591 67,143 25,863 Total stock-based compensation expense $ 255,515 $ 102,142 464,878 201,111 Benefit from income taxes (54,117) — (97,032) — Total stock-based compensation expense recorded to net income $ 201,398 $ 102,142 $ 367,846 $ 201,111

Income Taxes (Tables)

Income Taxes (Tables)	6 Months Ended
	Jul. 31, 2022
Income Tax Disclosure [Abstract]
Schedule of Provision for Income Taxes	The following table provides details of the provision for income taxes: Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 (in thousands, except percentages) Income before provision for income taxes $ 90,399 $ 323,884 $ 234,071 $ 552,815 Provision for income taxes 44,649 6,800 74,663 8,200 Effective tax rate 49.4 % 2.1 % 31.9 % 1.5 %

Net Income Per Share Attribut_2

Net Income Per Share Attributable to Common Stockholders (Tables)	6 Months Ended
	Jul. 31, 2022
Earnings Per Share [Abstract]
Schedule of Computation of Basic and Diluted Net Income Per Share	The following table sets forth the computation of basic and diluted net income per share attributable to common stockholders for the periods presented: Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Class A Class B Class A Class B Class A Class B Class A Class B (in thousands, except share and per share data) Numerator: Net income $ 38,594 $ 7,156 $ 255,513 $ 61,571 $ 134,075 $ 25,333 $ 431,889 $ 112,726 Less: undistributed earnings attributable to participating securities — (4) — (154) — (19) — (309) Net income attributable to common stockholders, basic $ 38,594 $ 7,152 $ 255,513 $ 61,417 $ 134,075 $ 25,314 $ 431,889 $ 112,417 Reallocation of net income attributable to common stockholders (518) 518 (5,738) 5,738 (1,959) 1,959 (10,105) 10,105 Net income attributable to common stockholders, diluted $ 38,076 $ 7,670 $ 249,775 $ 67,155 $ 132,116 $ 27,273 $ 421,784 $ 122,522 Denominator: Weighted-average shares used in computing net income per share attributable to common stockholders, basic 251,878,556 46,674,823 238,407,148 57,305,527 251,400,283 47,465,393 233,889,833 60,879,786 Weighted-average shares used in computing net income per share attributable to common stockholders, diluted 255,661,184 51,499,656 241,051,560 64,809,491 254,389,537 52,513,427 236,850,849 68,801,779 Net income per share attributable to common stockholders, basic $ 0.15 $ 0.15 $ 1.07 $ 1.07 $ 0.53 $ 0.53 $ 1.85 $ 1.85 Net income per share attributable to common stockholders, diluted $ 0.15 $ 0.15 $ 1.04 $ 1.04 $ 0.52 $ 0.52 $ 1.78 $ 1.78
Schedule of Potential Shares of Common Stock Excluded from Computation of Diluted Net Income Per Share Attributable to Common Stockholders	The potential shares of common stock that were excluded from the computation of diluted net income per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive, are as follows: Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Class A Class B Class A Class B Class A Class B Class A Class B Unvested RSUs 6,451,823 — 323,313 — 5,113,608 — 301,179 — Purchase rights committed under the ESPP 1,757,812 — 247,321 — 995,341 — 134,576 — Outstanding stock options 103,406 — — — 51,703 — — — Total 8,313,041 — 570,634 — 6,160,652 — 435,755 —

Revenue Recognition - Summary D

Revenue Recognition - Summary Disaggregation of Revenue by Region (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Disaggregation of Revenue [Line Items]
Revenue	$ 1,099,458	$ 1,021,495	$ 2,173,258	$ 1,977,732
Revenue from Contract with Customer Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as a percent)	100%	100%	100%	100%
Americas
Disaggregation of Revenue [Line Items]
Revenue	$ 762,690	$ 681,414	$ 1,491,071	$ 1,317,199
Americas | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as a percent)	69%	67%	69%	67%
Asia Pacific (“APAC”)
Disaggregation of Revenue [Line Items]
Revenue	$ 149,355	$ 135,321	$ 298,175	$ 259,084
Asia Pacific (“APAC”) | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as a percent)	14%	13%	14%	13%
Europe, Middle East, and Africa (“EMEA”)
Disaggregation of Revenue [Line Items]
Revenue	$ 187,413	$ 204,760	$ 384,012	$ 401,449
Europe, Middle East, and Africa (“EMEA”) | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as a percent)	17%	20%	17%	20%

Revenue Recognition - Contract

Revenue Recognition - Contract Balances (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021	Jan. 31, 2022
Revenue from Contract with Customer [Abstract]
Unbilled contracts receivable	$ 70.6		$ 70.6		$ 59.7
Revenue recognized included in deferred revenue	$ 572.7	$ 480.5	$ 867.6	$ 660.1

Revenue Recognition - Remaining

Revenue Recognition - Remaining Performance Obligation (Details) $ in Millions	Jul. 31, 2022 USD ($)
Disaggregation of Revenue [Line Items]
Remaining performance obligation	$ 3,213
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-08-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation (as a percent)	61%
Revenue remaining performance obligation, expected timing of satisfaction period (in months)	12 months
Billed consideration
Disaggregation of Revenue [Line Items]
Remaining performance obligation	$ 1,401.1
Unbilled consideration
Disaggregation of Revenue [Line Items]
Remaining performance obligation	$ 1,811.9

Investments - Summary of Market

Investments - Summary of Marketable Securities (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Marketable Securities [Line Items]
Amortized Cost	$ 4,646,483	$ 4,380,350
Gross Unrealized Gains	590	35
Gross Unrealized Losses	(64,365)	(23,939)
Estimated Fair Value	4,582,708	4,356,446
Commercial paper
Marketable Securities [Line Items]
Amortized Cost	64,596	28,723
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	64,596	28,723
Agency bonds
Marketable Securities [Line Items]
Amortized Cost	654,632	632,935
Gross Unrealized Gains	165	2
Gross Unrealized Losses	(10,965)	(3,328)
Estimated Fair Value	643,832	629,609
Corporate and other debt securities
Marketable Securities [Line Items]
Amortized Cost	411,999	282,124
Gross Unrealized Gains	81	5
Gross Unrealized Losses	(3,615)	(1,202)
Estimated Fair Value	408,465	280,927
U.S. government agency securities
Marketable Securities [Line Items]
Amortized Cost	3,433,437	3,046,742
Gross Unrealized Gains	344	28
Gross Unrealized Losses	(49,538)	(19,261)
Estimated Fair Value	3,384,243	3,027,509
Treasury bills
Marketable Securities [Line Items]
Amortized Cost	81,819	389,826
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(247)	(148)
Estimated Fair Value	$ 81,572	$ 389,678

Investments - Additional Inform

Investments - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Jul. 31, 2022	Jan. 31, 2022
Fair Value, Separate Account Investment [Line Items]
Unrealized losses for securities in unrealized loss position for less than 12 months	$ 56,400	$ 23,300
Unrealized losses for securities in unrealized loss position for 12 months or longer	8,000	0
Fair Value
Fair Value, Separate Account Investment [Line Items]
Equity securities	139,908	$ 168,784
Strategic Investment Of Technology Company
Fair Value, Separate Account Investment [Line Items]
Purchase of strategic investments	40,000
Unrealized loss on securities	12,200
Strategic Investment Of Technology Company | Fair Value
Fair Value, Separate Account Investment [Line Items]
Equity securities	$ 27,800
Ownership percentage (less than) (as a percent)	1%

Investments - Summary of Contra

Investments - Summary of Contractual Maturities of Marketable Securities (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Less than one year	$ 2,827,538	$ 2,387,139
Due in one to five years	1,755,170	1,969,307
Total	$ 4,582,708	$ 4,356,446

Investments - Schedule of Strat

Investments - Schedule of Strategic Investments (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Measurement Alternative	$ 112,064	$ 91,399
Equity Method	92,603	93,400
Total equity securities	344,575	353,583
Debt securities	13,673	14,231
Fair value of strategic investments	153,581	183,015
Total strategic investments	358,248	367,814
Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities	139,908	168,784
Debt securities	$ 13,673	$ 14,231

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Financial Assets:
Marketable securities	$ 4,582,708	$ 4,356,446
Commercial paper
Financial Assets:
Marketable securities	64,596	28,723
Agency bonds
Financial Assets:
Marketable securities	643,832	629,609
Corporate and other debt securities
Financial Assets:
Marketable securities	408,465	280,927
U.S. government agency securities
Financial Assets:
Marketable securities	3,384,243	3,027,509
Fair Value, Recurring Basis
Financial Assets:
Cash equivalents	587,393	796,967
Marketable securities	4,582,708	4,356,446
Publicly held equity securities included in strategic investments	139,908	168,784
Total financial assets	5,323,951	5,336,725
Fair Value, Recurring Basis | Commercial paper
Financial Assets:
Marketable securities	64,596	28,723
Fair Value, Recurring Basis | Agency bonds
Financial Assets:
Marketable securities	643,832	629,609
Fair Value, Recurring Basis | Corporate and other debt securities
Financial Assets:
Marketable securities	408,465	280,927
Fair Value, Recurring Basis | U.S. government agency securities
Financial Assets:
Marketable securities	3,384,243	3,027,509
Fair Value, Recurring Basis | Treasury bills
Financial Assets:
Marketable securities	81,572	389,678
Fair Value, Recurring Basis | Privately held debt securities included in strategic investments
Financial Assets:
Marketable securities	13,673	14,231
Fair Value, Recurring Basis | Certificates of deposit included in other assets, noncurrent
Financial Assets:
Certificates of deposit included in other assets, noncurrent	269	297
Fair Value, Recurring Basis | Money market funds
Financial Assets:
Cash equivalents	521,527	688,722
Fair Value, Recurring Basis | Treasury bills
Financial Assets:
Cash equivalents	50	107,496
Fair Value, Recurring Basis | Commercial paper
Financial Assets:
Cash equivalents	670
Fair Value, Recurring Basis | Corporate debt securities
Financial Assets:
Cash equivalents		749
Fair Value, Recurring Basis | U.S. government agency securities
Financial Assets:
Cash equivalents	49,197
Fair Value, Recurring Basis | Agency bonds
Financial Assets:
Cash equivalents	15,949
Fair Value, Recurring Basis | Level 1
Financial Assets:
Cash equivalents	521,527	688,722
Marketable securities	0	0
Publicly held equity securities included in strategic investments	139,908	168,784
Total financial assets	661,435	857,506
Fair Value, Recurring Basis | Level 1 | Commercial paper
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis | Level 1 | Agency bonds
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis | Level 1 | Corporate and other debt securities
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis | Level 1 | U.S. government agency securities
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis | Level 1 | Treasury bills
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis | Level 1 | Privately held debt securities included in strategic investments
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis | Level 1 | Certificates of deposit included in other assets, noncurrent
Financial Assets:
Certificates of deposit included in other assets, noncurrent	0	0
Fair Value, Recurring Basis | Level 1 | Money market funds
Financial Assets:
Cash equivalents	521,527	688,722
Fair Value, Recurring Basis | Level 1 | Treasury bills
Financial Assets:
Cash equivalents	0	0
Fair Value, Recurring Basis | Level 1 | Commercial paper
Financial Assets:
Cash equivalents	0
Fair Value, Recurring Basis | Level 1 | Corporate debt securities
Financial Assets:
Cash equivalents		0
Fair Value, Recurring Basis | Level 1 | U.S. government agency securities
Financial Assets:
Cash equivalents	0
Fair Value, Recurring Basis | Level 1 | Agency bonds
Financial Assets:
Cash equivalents	0
Fair Value, Recurring Basis | Level 2
Financial Assets:
Cash equivalents	65,866	108,245
Marketable securities	4,582,708	4,356,446
Publicly held equity securities included in strategic investments	0	0
Total financial assets	4,648,843	4,464,988
Fair Value, Recurring Basis | Level 2 | Commercial paper
Financial Assets:
Marketable securities	64,596	28,723
Fair Value, Recurring Basis | Level 2 | Agency bonds
Financial Assets:
Marketable securities	643,832	629,609
Fair Value, Recurring Basis | Level 2 | Corporate and other debt securities
Financial Assets:
Marketable securities	408,465	280,927
Fair Value, Recurring Basis | Level 2 | U.S. government agency securities
Financial Assets:
Marketable securities	3,384,243	3,027,509
Fair Value, Recurring Basis | Level 2 | Treasury bills
Financial Assets:
Marketable securities	81,572	389,678
Fair Value, Recurring Basis | Level 2 | Privately held debt securities included in strategic investments
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis | Level 2 | Certificates of deposit included in other assets, noncurrent
Financial Assets:
Certificates of deposit included in other assets, noncurrent	269	297
Fair Value, Recurring Basis | Level 2 | Money market funds
Financial Assets:
Cash equivalents	0	0
Fair Value, Recurring Basis | Level 2 | Treasury bills
Financial Assets:
Cash equivalents	50	107,496
Fair Value, Recurring Basis | Level 2 | Commercial paper
Financial Assets:
Cash equivalents	670
Fair Value, Recurring Basis | Level 2 | Corporate debt securities
Financial Assets:
Cash equivalents		749
Fair Value, Recurring Basis | Level 2 | U.S. government agency securities
Financial Assets:
Cash equivalents	49,197
Fair Value, Recurring Basis | Level 2 | Agency bonds
Financial Assets:
Cash equivalents	15,949
Fair Value, Recurring Basis | Level 3
Financial Assets:
Cash equivalents	0	0
Marketable securities	0	0
Publicly held equity securities included in strategic investments	0	0
Total financial assets	13,673	14,231
Fair Value, Recurring Basis | Level 3 | Commercial paper
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis | Level 3 | Agency bonds
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis | Level 3 | Corporate and other debt securities
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis | Level 3 | U.S. government agency securities
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis | Level 3 | Treasury bills
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis | Level 3 | Privately held debt securities included in strategic investments
Financial Assets:
Marketable securities	13,673	14,231
Fair Value, Recurring Basis | Level 3 | Certificates of deposit included in other assets, noncurrent
Financial Assets:
Certificates of deposit included in other assets, noncurrent	0	0
Fair Value, Recurring Basis | Level 3 | Money market funds
Financial Assets:
Cash equivalents	0	0
Fair Value, Recurring Basis | Level 3 | Treasury bills
Financial Assets:
Cash equivalents	0	0
Fair Value, Recurring Basis | Level 3 | Commercial paper
Financial Assets:
Cash equivalents	0
Fair Value, Recurring Basis | Level 3 | Corporate debt securities
Financial Assets:
Cash equivalents		$ 0
Fair Value, Recurring Basis | Level 3 | U.S. government agency securities
Financial Assets:
Cash equivalents	0
Fair Value, Recurring Basis | Level 3 | Agency bonds
Financial Assets:
Cash equivalents	$ 0

Business Combinations (Details)

Business Combinations (Details) - USD ($) $ in Thousands		6 Months Ended
	May 19, 2022	Jul. 31, 2022	Jan. 31, 2022
Business Acquisition [Line Items]
Goodwill		$ 122,556	$ 27,607
Solvvy, Inc.
Business Acquisition [Line Items]
Business acquisition, percentage of voting interests acquired (as a percent)	100%
Cash consideration paid	$ 121,200
Goodwill	94,900
Intangible assets, other than goodwill	26,700
Other net liabilities acquired	(400)
Solvvy, Inc. | Developed Technology Rights
Business Acquisition [Line Items]
Intangible assets, other than goodwill	$ 12,000
Acquired finite-lived intangible assets, weighted average useful life (in years)	5 years	4 years 9 months 18 days
Solvvy, Inc. | Customer Relationships
Business Acquisition [Line Items]
Intangible assets, other than goodwill	$ 14,700
Acquired finite-lived intangible assets, weighted average useful life (in years)	5 years	4 years 9 months 18 days

Balance Sheet Components - Sche

Balance Sheet Components - Schedule of Accounts Receivable (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022	Jul. 31, 2021	Jan. 31, 2021
Property, Plant and Equipment [Abstract]
Accounts receivable, gross	$ 541,947	$ 444,369
Less: allowance for credit losses	(23,200)	(17,000)	$ (17,500)	$ (20,500)
Less: allowance for returns	(9,204)	(7,696)
Accounts receivable, net	$ 509,543	$ 419,673

Balance Sheet Components - Roll

Balance Sheet Components - Rollforward of Allowance For Credit Losses (Details) - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	$ 17,000	$ 20,500
Provision for credit losses	25,606	8,029
Write-offs	(19,406)	(11,029)
Ending balance	$ 23,200	$ 17,500

Balance Sheet Components - Prep

Balance Sheet Components - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Balance Sheet Components [Abstract]
Prepaid expenses	$ 126,857	$ 112,666
Other receivables	17,211	20,423
Restricted cash from international employee stock sales	5,708	10,236
Other	9,710	2,277
Prepaid expenses and other current assets	$ 159,486	$ 145,602

Balance Sheet Components - Sc_2

Balance Sheet Components - Schedule of Property and Equipment Net (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 358,392	$ 313,959
Less: accumulated depreciation and amortization	(119,290)	(91,605)
Property and equipment, net	239,102	222,354
Servers
Property, Plant and Equipment [Line Items]
Property and equipment, gross	213,578	185,491
Software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	69,692	59,153
Computer and office equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	45,241	39,410
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	25,313	25,340
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 4,568	$ 4,565

Balance Sheet Components - Addi

Balance Sheet Components - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Balance Sheet Components [Abstract]
Depreciation and amortization expense	$ 19.6	$ 11.8	$ 34.7	$ 22.3

Balance Sheet Components - Othe

Balance Sheet Components - Other Noncurrent Assets (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Balance Sheet Components [Abstract]
Accounts receivable, noncurrent	$ 82,175	$ 55,643
Intangible assets subject to amortization, net	28,174	2,972
Indefinite-lived intangible assets	24,232	21,020
Prepaid expenses, noncurrent	9,746	16,120
Other	9,971	11,006
Other assets, noncurrent	$ 154,298	$ 106,761

Balance Sheet Components - Sc_3

Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Balance Sheet Components [Abstract]
Accrued expenses	$ 168,860	$ 149,658
Accrued compensation and benefits	127,236	126,322
Income tax liabilities	106,313	56,968
Sales and other non-income tax liabilities	34,103	33,305
Customer deposit liabilities	23,703	20,884
Operating lease liabilities, current	21,986	20,697
Other	16,057	22,581
Accrued expenses and other current liabilities	$ 498,258	$ 430,415

Balance Sheet Components - Sc_4

Balance Sheet Components - Schedule of Other Liabilities Non Current (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Balance Sheet Components [Abstract]
Sales and other non-income tax liabilities	$ 41,747	$ 53,916
Other	17,099	14,194
Other liabilities, noncurrent	$ 58,846	$ 68,110

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Millions	Oct. 21, 2021 USD ($)	Jul. 30, 2020 officer	Jun. 11, 2020 officer	Apr. 08, 2020 officer	Nov. 17, 2021 lawsuit
Other Commitments [Line Items]
Number of derivative lawsuits | lawsuit					3
Violation Of Securities Act Section 10(b), 20(a), and Rule 10b-5
Other Commitments [Line Items]
Loss contingency, number of defendants | officer		8	9	2
U.S. Privacy Class Actions
Other Commitments [Line Items]
Payments for legal settlements | $	$ 85

Stockholders_ Equity and Equi_3

Stockholders’ Equity and Equity Incentive Plans - Additional Information (Details)	3 Months Ended	6 Months Ended
	Jul. 31, 2022 USD ($) plan $ / shares shares	Jul. 31, 2022 USD ($) plan $ / shares shares	Feb. 28, 2022 USD ($)	Jan. 31, 2022 $ / shares shares	Apr. 30, 2019 $ / shares shares
Class of Stock [Line Items]
Common stock, par value (in dollars per share) | $ / shares	$ 0.001	$ 0.001		$ 0.001
Stock repurchase plan, authorized amount (up to)			$ 1,000,000,000
Stock repurchased and retired during period (in shares) | shares	2,864,721	4,088,971
Stock repurchased and retired during period	$ 293,500,000	$ 425,900,000
Remaining authorized amount	$ 574,100,000	$ 574,100,000
Number of equity incentive plans | plan	2	2
Stock options
Class of Stock [Line Items]
Unrecognized stock-based compensation expenses related to outstanding unvested stock options	$ 7,300,000	$ 7,300,000
Unrecognized stock-based compensation excepted to be recognized over a weighted-average period (in years)		6 months
RSUs
Class of Stock [Line Items]
Unrecognized stock-based compensation excepted to be recognized over a weighted-average period (in years)		3 years
Unrecognized stock-based compensation expenses	2,481,100,000	$ 2,481,100,000
Employee Stock Purchase Plan
Class of Stock [Line Items]
Unrecognized stock-based compensation excepted to be recognized over a weighted-average period (in years)		1 year 6 months
Unrecognized stock-based compensation expenses	$ 85,500,000	$ 85,500,000
Class A Common Stock
Class of Stock [Line Items]
Common stock, authorized (in shares) | shares	2,000,000,000	2,000,000,000		2,000,000,000
Class A Common Stock | Initial public offering
Class of Stock [Line Items]
Common stock, authorized (in shares) | shares					2,000,000,000
Common stock, par value (in dollars per share) | $ / shares					$ 0.001
Class B Common Stock
Class of Stock [Line Items]
Common stock, authorized (in shares) | shares	300,000,000	300,000,000		300,000,000
Class B Common Stock | Initial public offering
Class of Stock [Line Items]
Common stock, authorized (in shares) | shares					300,000,000
Common stock, par value (in dollars per share) | $ / shares					$ 0.001

Stockholders_ Equity and Equi_4

Stockholders’ Equity and Equity Incentive Plans - Summary of Stock Option Activity Under Equity Incentive Plan (Details) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Jul. 31, 2022 USD ($) $ / shares shares	Jan. 31, 2022 USD ($) $ / shares shares
Outstanding Stock Options
Beginning balance (in shares) | shares	6,195,205
Exercised (in shares) | shares	(858,055)
Cancelled/forfeited/expired (in shares) | shares	(83,072)
Ending balance (in shares) | shares	5,254,078	6,195,205
Vested and expected to vest (in shares) | shares	5,254,078
Exercisable (in shares) | shares	4,869,691
Weighted- Average Exercise Price
Beginning balance (in dollars per share) | $ / shares	$ 8.08
Exercised (in dollars per share) | $ / shares	5.90
Cancelled/forfeited/expired (in dollars per share) | $ / shares	21.48
Ending balance (in dollars per share) | $ / shares	8.22	$ 8.08
Weighted average exercise price, vested and expected to vest (in dollars per share) | $ / shares	8.22
Weighted average exercise price, exercisable (in dollars per share) | $ / shares	$ 6.81
Weighted- Average Remaining Contractual Life (Years)
Outstanding (in years)	5 years 6 months	6 years
Vested and expected to vest (in years)	5 years 6 months
Weighted-average remaining contractual life, exercisable (in years)	5 years 4 months 24 days
Aggregate Intrinsic Value
Outstanding | $	$ 502,488	$ 905,744
Exercised | $	91,811
Vested and expected to vest | $	502,488
Options outstanding, aggregate intrinsic value, exercisable | $	$ 472,618

Stockholders_ Equity and Equi_5

Stockholders’ Equity and Equity Incentive Plans - Summary of Restricted Stock Units Activity Under Equity Incentive Plan (Details) - RSUs	6 Months Ended
	Jul. 31, 2022 $ / shares shares
Unvested RSUs
Beginning balance (in shares) | shares	5,546,366
Granted (in shares) | shares	10,737,425
Vested (in shares) | shares	(1,906,359)
Cancelled/forfeited (in shares) | shares	(826,734)
Ending balance (in shares) | shares	13,550,698
Weighted- Average Grant Date Fair Value Per Share
Beginning balance (in dollars per share) | $ / shares	$ 232.58
Granted (in dollars per share) | $ / shares	110.99
Vested (in dollars per share) | $ / shares	189.17
Cancelled/forfeited (in dollars per share) | $ / shares	173.54
Ending balance (in dollars per share) | $ / shares	$ 145.93

Stockholders_ Equity and Equi_6

Stockholders’ Equity and Equity Incentive Plans - Summary of Stock-based Compensation Expense by Line Item (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	$ 255,515	$ 102,142	$ 464,878	$ 201,111
Benefit from income taxes	(54,117)	0	(97,032)	0
Total stock-based compensation expense recorded to net income	201,398	102,142	367,846	201,111
Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	37,177	14,778	68,327	28,844
Research and development
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	69,701	22,917	125,452	43,736
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	110,161	50,856	203,956	102,668
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	$ 38,476	$ 13,591	$ 67,143	$ 25,863

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Income Tax Disclosure [Abstract]
Income before provision for income taxes	$ 90,399	$ 323,884	$ 234,071	$ 552,815
Provision for income taxes	$ 44,649	$ 6,800	$ 74,663	$ 8,200
Effective tax rate (as a percent)	49.40%	2.10%	31.90%	1.50%

Net Income Per Share Attribut_3

Net Income Per Share Attributable to Common Stockholders - Schedule of Computation of Basic and Diluted Net Income Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Numerator:
Net income	$ 45,750	$ 317,084	$ 159,408	$ 544,615
Net income attributable to common stockholders	$ 45,746	$ 316,930	$ 159,389	$ 544,306
Denominator:
Weighted-average shares used in computing net income per share attributable to common stockholders, basic (in shares)	298,553,379	295,712,675	298,865,676	294,769,619
Weighted-average shares used in computing net income per share attributable to common stockholders, diluted (in shares)	307,160,840	305,861,051	306,902,964	305,652,628
Net income per share attributable to common stockholders, basic (in dollars per share)	$ 0.15	$ 1.07	$ 0.53	$ 1.85
Net income per share attributable to common stockholders, diluted (in dollars per share)	$ 0.15	$ 1.04	$ 0.52	$ 1.78
Class A Common Stock
Numerator:
Net income	$ 38,594	$ 255,513	$ 134,075	$ 431,889
Less: undistributed earnings attributable to participating securities	0	0	0	0
Net income attributable to common stockholders	38,594	255,513	134,075	431,889
Reallocation of net income attributable to common stockholders	(518)	(5,738)	(1,959)	(10,105)
Net income attributable to common stockholders, diluted	$ 38,076	$ 249,775	$ 132,116	$ 421,784
Denominator:
Weighted-average shares used in computing net income per share attributable to common stockholders, basic (in shares)	251,878,556	238,407,148	251,400,283	233,889,833
Weighted-average shares used in computing net income per share attributable to common stockholders, diluted (in shares)	255,661,184	241,051,560	254,389,537	236,850,849
Net income per share attributable to common stockholders, basic (in dollars per share)	$ 0.15	$ 1.07	$ 0.53	$ 1.85
Net income per share attributable to common stockholders, diluted (in dollars per share)	$ 0.15	$ 1.04	$ 0.52	$ 1.78
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	8,313,041	570,634	6,160,652	435,755
Class A Common Stock | Outstanding stock options
Denominator:
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	103,406	0	51,703	0
Class B Common Stock
Numerator:
Net income	$ 7,156	$ 61,571	$ 25,333	$ 112,726
Less: undistributed earnings attributable to participating securities	(4)	(154)	(19)	(309)
Net income attributable to common stockholders	7,152	61,417	25,314	112,417
Reallocation of net income attributable to common stockholders	518	5,738	1,959	10,105
Net income attributable to common stockholders, diluted	$ 7,670	$ 67,155	$ 27,273	$ 122,522
Denominator:
Weighted-average shares used in computing net income per share attributable to common stockholders, basic (in shares)	46,674,823	57,305,527	47,465,393	60,879,786
Weighted-average shares used in computing net income per share attributable to common stockholders, diluted (in shares)	51,499,656	64,809,491	52,513,427	68,801,779
Net income per share attributable to common stockholders, basic (in dollars per share)	$ 0.15	$ 1.07	$ 0.53	$ 1.85
Net income per share attributable to common stockholders, diluted (in dollars per share)	$ 0.15	$ 1.04	$ 0.52	$ 1.78
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	0	0	0
Class B Common Stock | Outstanding stock options
Denominator:
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	0	0	0

Net Income Per Share Attribut_4

Net Income Per Share Attributable to Common Stockholders - Summary of Potential Shares of Common Stock Excluded from Computation of Diluted Net Income Per Share Attributable to Common Stockholders (Details) - shares	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Class A Common Stock
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	8,313,041	570,634	6,160,652	435,755
Class A Common Stock | Unvested RSUs
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	6,451,823	323,313	5,113,608	301,179
Class A Common Stock | Purchase rights committed under the ESPP
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	1,757,812	247,321	995,341	134,576
Class A Common Stock | Held For Charitable Contributions
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)			405,156	405,156
Class B Common Stock
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	0	0	0
Class B Common Stock | Unvested RSUs
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	0	0	0
Class B Common Stock | Purchase rights committed under the ESPP
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	0	0	0